Transcat, Inc. Expands Life Science Market Penetration with BioTek Services, Inc. Acquisition
Posted:
December 16, 2020
Categories:
Investor Relations News
ROCHESTER, NY, December 16, 2020 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it has acquired substantially all of the assets of BioTek Services, Inc. (“BioTek”), effective December 16, 2020. The purchase price was $3.5 million and is subject to certain customary holdback provisions.
My Saved Items
Categories
Recent Posts
Archive
Tags